&lt;h2&gt;&lt;strong&gt;Apretude in Thailand: Trailblazing Injectable HIV Pre-Exposure Prophylaxis (PrEP) Now Approved in Thailand&lt;/strong&gt;&lt;/h2&gt;
&lt;p&gt;If needles make you nervous, it&amp;rsquo;s time to face that fear. On December 20, 2021, the US Food and Drug Administration (FDA) approved Apretude, the first injectable option for HIV PrEP.&lt;/p&gt;
&lt;p&gt;Apretude, an extended-release formulation of cabotegravir, has proven more effective in preventing HIV than daily PrEP pills, according to two major studies. This advancement promises significant benefits for sexual health across various communities.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;h3&gt;&lt;strong&gt;Quick, Easy, and Convenient for Everyone&lt;/strong&gt;&lt;/h3&gt;
&lt;p&gt;Instead of daily PrEP pills, a healthcare professional administers Apretude every two months. All you need is a brief appointment, and you&amp;rsquo;re protected against HIV within minutes.&lt;/p&gt;
&lt;p&gt;Apretude is FDA-approved for adults and teens weighing at least 35 kg. Regardless of whether you are cis-gendered or transgendered, it&amp;rsquo;s effective for all sexual activities.&lt;/p&gt;
&lt;p&gt;This is particularly noteworthy since PrEP pills have limitations. For instance, on-demand pills are only effective for cisgender males engaging in anal sex, and options like Descovy are not suitable for cisgender females due to a lack of research.&lt;/p&gt;
&lt;p&gt;Apretude is said to reduce the risk of contracting HIV by 92% compared to daily pills, boasting the highest efficacy for PrEP among women, as reported by scientists.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;h3&gt;&lt;strong&gt;Guaranteed Safe and Effective&lt;/strong&gt;&lt;/h3&gt;
&lt;p&gt;For those without access to daily medications or who struggle with adherence, this breakthrough offers a promising solution. Here&amp;rsquo;s how it works:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;&lt;strong&gt;Initial HIV Test&lt;/strong&gt;: A healthcare professional tests for HIV.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Starting Dose&lt;/strong&gt;: People may start with either two monthly injections or a month of cabotegravir pills depending on their health assessment; injections are given in the buttocks.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Ongoing Protection&lt;/strong&gt;: After the first two months, Apretude is administered every two months.&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;You have a 7-day window around your appointment to get the injection. If you miss this window by a week, clinicians can provide daily cabotegravir pills for up to two months until you resume injections.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;h3&gt;&lt;strong&gt;Side Effects of Apretude in Thailand&lt;/strong&gt;&lt;/h3&gt;
&lt;p&gt;Similar to other injections, there may be redness or swelling at the injection site, which typically resolves within a few days.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;h3&gt;&lt;strong&gt;A Game-Changing Solution to End the HIV Epidemic&lt;/strong&gt;&lt;/h3&gt;
&lt;p&gt;Daily pills can be challenging due to various factors like misplacement, forgetfulness, and fears of medication disclosure. As TruEvolution CEO and executive director Gabriel Maldonado explains:&lt;/p&gt;
&lt;p&gt;&amp;ldquo;This [complication] includes stigma, fears of accidental disclosure, and general daily life challenges, contributing to low rates of PrEP usage and fuelling the HIV epidemic.&amp;rdquo;&lt;/p&gt;
&lt;p&gt;Apretude offers a safe, convenient alternative, allowing individuals to lead healthier sexual lives without shame or hassle&amp;mdash;all with just six injections a year.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;What are your thoughts on Apretude?&lt;/strong&gt; Would you consider it once it&amp;rsquo;s available in Asia? We&amp;rsquo;d love to hear your opinions!&lt;/p&gt;
&lt;h3&gt;&amp;nbsp;&lt;/h3&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;h3&gt;&lt;strong&gt;APRETUDE for Different Communities&lt;/strong&gt;&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;Women&lt;/strong&gt; APRETUDE caters to women&amp;rsquo;s unique health needs, providing a reliable, hassle-free HIV prevention option.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Men&lt;/strong&gt; For men, APRETUDE eliminates the daily pill burden, offering consistent protection without daily reminders.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Gay Men&lt;/strong&gt; APRETUDE benefits gay men by improving adherence and offering a discreet prevention method.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Transgender Individuals&lt;/strong&gt; Transgender individuals face unique healthcare challenges. APRETUDE supports transgender health by offering an effective, convenient HIV prevention option.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;h2&gt;&lt;strong&gt;Efficacy of Apretude for all populations&lt;/strong&gt;&lt;/h2&gt;
&lt;hr /&gt;
&lt;p class=&quot;&quot;&gt;Based on the research study&lt;/p&gt;
&lt;table style=&quot;border-collapse: collapse; width: 100%; height: 90px;&quot; border=&quot;1&quot;&gt;
&lt;tbody&gt;
&lt;tr style=&quot;height: 18px;&quot;&gt;
&lt;td style=&quot;width: 16.6667%; height: 18px;&quot;&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot; colspan=&quot;5&quot;&gt;Injectable PrEP Apretude Efficacy in Different Populations&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 18px;&quot;&gt;
&lt;td style=&quot;width: 16.6667%; height: 18px;&quot;&gt;&lt;strong&gt;Route or Sex&lt;/strong&gt;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;&lt;strong&gt;Straight Men&lt;/strong&gt;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;&lt;strong&gt;Straight Women&lt;/strong&gt;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;&lt;strong&gt;Gay and Bisexuals&lt;/strong&gt;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;&lt;strong&gt;TransWomem&lt;/strong&gt;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;&lt;strong&gt;TransMen&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 18px;&quot;&gt;
&lt;td style=&quot;width: 16.6667%; height: 18px;&quot;&gt;Oral Sex&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 18px;&quot;&gt;
&lt;td style=&quot;width: 16.6667%; height: 18px;&quot;&gt;Anal Sex&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 18px;&quot;&gt;
&lt;td style=&quot;width: 16.6667%; height: 18px;&quot;&gt;Vaginal Sex&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;h2&gt;&lt;br /&gt;&lt;strong&gt;SUPERIOR HIV PROTECTION VS TRUVADA&lt;/strong&gt;&lt;/h2&gt;
&lt;hr /&gt;
&lt;h3&gt;&amp;nbsp;&lt;/h3&gt;
&lt;p style=&quot;text-align: center;&quot;&gt;&lt;img src=&quot;https://cms.pulse-clinic.com/Files/Apretude%20PrEP%20Injection/Apretude%20Info%20Graphic/7-apretude-men.jpg&quot; width=&quot;500&quot; height=&quot;500&quot; /&gt;&amp;nbsp;&amp;nbsp;&lt;img src=&quot;https://cms.pulse-clinic.com/Files/Apretude%20PrEP%20Injection/Apretude%20Info%20Graphic/9-apretude-men.jpg&quot; width=&quot;500&quot; height=&quot;500&quot; /&gt;&lt;/p&gt;
&lt;h3&gt;&lt;strong&gt;STUDY IN CISGENDER MEN AND TRANSGENDER WOMEN&lt;/strong&gt;&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;&lt;span class=&quot;selection-italic&quot;&gt;&lt;span class=&quot;color-5&quot;&gt;Significantly more people stayed HIV-negative on APRETUDE vs TRUVADA during the study.&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;69% reduction in the risk of acquiring HIV-1 with APRETUDE (0.37/100 person-years) vs TRUVADA (1.22/100 person-years)&lt;/p&gt;
&lt;h2&gt;&lt;img src=&quot;https://apretude.com/content/dam/cf-viiv/apretude-v2/en_US/2-1/Graphic_hiv-infection-line-graph_m.svg&quot; style=&quot;display: block; margin-left: auto; margin-right: auto;&quot; /&gt;&lt;/h2&gt;
&lt;p style=&quot;text-align: center;&quot;&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style=&quot;text-align: center;&quot;&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;img src=&quot;https://apretude.com/content/dam/cf-viiv/apretude-v2/en_US/2-1/Graphic_hiv-infection-line-graph_dt.svg&quot; style=&quot;display: block; margin-left: auto; margin-right: auto;&quot; /&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: center;&quot;&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style=&quot;text-align: center;&quot;&gt;&amp;nbsp;&lt;/p&gt;
&lt;h3&gt;&lt;strong&gt;STUDY IN CISGENDER WOMEN&lt;/strong&gt;&lt;/h3&gt;
&lt;div class=&quot;richText component section padding-left-0 padding-right-0 even col-xs-12&quot;&gt;
&lt;div class=&quot;component-content&quot;&gt;
&lt;div class=&quot;richText-content&quot;&gt;&lt;strong&gt;&lt;span class=&quot;selection-italic&quot;&gt;&lt;span class=&quot;color-2&quot;&gt;Significantly more women stayed HIV-negative on APRETUDE vs TRUVADA during the study.&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span class=&quot;selection-italic&quot;&gt;&lt;span class=&quot;color-2&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;richText-content&quot;&gt;&lt;span class=&quot;selection-italic&quot;&gt;&lt;span class=&quot;color-2&quot;&gt;&lt;span class=&quot;selection-bold&quot;&gt;90% reduction in the risk of acquiring HIV-1 with APRETUDE&lt;/span&gt;&amp;nbsp;(0.15/100 person-years) vs TRUVADA (1.85/100 person-years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;richText-content&quot;&gt;&amp;nbsp;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;viiv-us-gc-17-image component section mobile-padding-top-3 padding-top-0 odd col-xs-12&quot;&gt;
&lt;div class=&quot;type1 variant1&quot;&gt;
&lt;div id=&quot;image_type1_variant1&quot; class=&quot;authorable-content&quot;&gt;
&lt;div class=&quot;image-wrapper&quot;&gt;
&lt;div class=&quot;image desktop center&quot;&gt;
&lt;div class=&quot;logotype&quot;&gt;&lt;img src=&quot;https://apretude.com/content/dam/cf-viiv/apretude-v2/en_US/2-1/Graphic_hiv-infection-data-line-graph_dt.svg&quot; style=&quot;display: block; margin-left: auto; margin-right: auto;&quot; /&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;h2&gt;&amp;nbsp;&lt;/h2&gt;
&lt;p style=&quot;text-align: center;&quot;&gt;&lt;strong&gt;&lt;img src=&quot;https://cms.pulse-clinic.com/Files/Apretude%20PrEP%20Injection/Apretude%20Info%20Graphic/4-apretude-men.jpg&quot; width=&quot;650&quot; height=&quot;650&quot; /&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;h2&gt;&amp;nbsp;&lt;/h2&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;h3&gt;&lt;strong&gt;Cost of APRETUDE&lt;/strong&gt;&lt;/h3&gt;
&lt;p&gt;In Thailand, VIIV Healthcare has priced APRETUDE, the new injectable PrEP, at 19,500 THB per dose every two months.&lt;/p&gt;
&lt;h3&gt;&amp;nbsp;&lt;/h3&gt;
&lt;h2&gt;&lt;strong&gt;Efficacy of Apretude for all populations&lt;/strong&gt;&lt;/h2&gt;
&lt;hr /&gt;
&lt;p class=&quot;&quot;&gt;Based on the research study&lt;/p&gt;
&lt;table style=&quot;border-collapse: collapse; width: 100%; height: 90px;&quot; border=&quot;1&quot;&gt;
&lt;tbody&gt;
&lt;tr style=&quot;height: 18px;&quot;&gt;
&lt;td style=&quot;width: 16.6667%; height: 18px;&quot;&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot; colspan=&quot;5&quot;&gt;Injectable PrEP Apretude Efficacy in Different Populations&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 18px;&quot;&gt;
&lt;td style=&quot;width: 16.6667%; height: 18px;&quot;&gt;&lt;strong&gt;Route or Sex&lt;/strong&gt;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;&lt;strong&gt;Straight Men&lt;/strong&gt;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;&lt;strong&gt;Straight Women&lt;/strong&gt;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;&lt;strong&gt;Gay and Bisexuals&lt;/strong&gt;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;&lt;strong&gt;TransWomem&lt;/strong&gt;&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;&lt;strong&gt;TransMen&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 18px;&quot;&gt;
&lt;td style=&quot;width: 16.6667%; height: 18px;&quot;&gt;Oral Sex&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 18px;&quot;&gt;
&lt;td style=&quot;width: 16.6667%; height: 18px;&quot;&gt;Anal Sex&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 18px;&quot;&gt;
&lt;td style=&quot;width: 16.6667%; height: 18px;&quot;&gt;Vaginal Sex&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;td style=&quot;width: 16.6667%; text-align: center; height: 18px;&quot;&gt;more than 99%&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;h3&gt;&amp;nbsp;&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;Benefits of Injectable PrEP&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;APRETUDE (cabotegravir) offers numerous benefits as a long-acting HIV pre-exposure prophylaxis (PrEP) option:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;High Efficacy&lt;/strong&gt;: Clinical trials show APRETUDE significantly reduces the risk of HIV-1 acquisition compared to daily oral PrEP, with over 99% effectiveness in real-world studies.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Convenience&lt;/strong&gt;: Administered as an injection every two months, APRETUDE removes the need for daily adherence.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Improved Adherence&lt;/strong&gt;: The long-acting nature of APRETUDE helps improve adherence to HIV prevention by removing the burden of daily pills.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Reduction in Stigma and Anxiety&lt;/strong&gt;: Real-world studies indicate APRETUDE reduces stigma and anxiety associated with daily oral PrEP, contributing to better mental health and quality of life.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Diverse Population&lt;/strong&gt;: Clinical trials involved a diverse range of participants, showing APRETUDE&#39;s broad applicability.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Long-Lasting Protection&lt;/strong&gt;: Each injection provides two months of continuous protection, offering reliable and sustained&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;https://www.eu-health.org/booking&quot;&gt;&lt;img src=&quot;https://cms.pulse-clinic.com/Files/Booking%20an%20appointment%20at%20PULSE%20CLINIC.png&quot; width=&quot;300&quot; height=&quot;37&quot; style=&quot;display: block; margin-left: auto; margin-right: auto;&quot; /&gt;&lt;/a&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: center;&quot;&gt;&lt;br /&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;We can help you with your emergency medication needs!&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: center;&quot;&gt;&lt;strong&gt;Please email us at&amp;nbsp;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;a href=&quot;mailto:info@eu-health.com&quot;&gt;info@eu-health.com&lt;/a&gt;&lt;/span&gt;&amp;nbsp;or chat on your preferred platform.&lt;br /&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: center;&quot;&gt;&amp;nbsp;&lt;/p&gt;
&lt;p style=&quot;text-align: center;&quot;&gt;&lt;strong&gt;&lt;a href=&quot;https://wa.me/66994797168&quot;&gt;&lt;/a&gt;&lt;a href=&quot;https://wa.me/66994797168&quot;&gt;&lt;img src=&quot;https://cms.pulse-clinic.com/Files/WhatsApp.png&quot; width=&quot;48&quot; height=&quot;82&quot; /&gt;&lt;/a&gt; +66-99-479-7168&amp;nbsp;&lt;/strong&gt;&lt;strong&gt;&lt;a href=&quot;https://line.me/ti/p/~@euwellness&quot;&gt;&lt;img src=&quot;https://cms.pulse-clinic.com/Files/line-logo.png&quot; width=&quot;50&quot; height=&quot;85&quot; /&gt;&lt;/a&gt;&amp;nbsp;&lt;a href=&quot;https://line.me/ti/p/~@euwellness&quot;&gt;@euwellness&lt;/a&gt;&amp;nbsp; &amp;nbsp;&amp;nbsp;&lt;/strong&gt;&lt;strong&gt;&lt;a href=&quot;https://api.whatsapp.com/send/?phone=%2B66994797168&amp;amp;text&amp;amp;type=phone_number&amp;amp;app_absent=0&quot;&gt;&lt;img src=&quot;https://cms.pulse-clinic.com/Files/WeChat_App_Icon.png&quot; width=&quot;50&quot; height=&quot;85&quot; /&gt;&lt;/a&gt;&amp;nbsp;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;a href=&quot;https://wa.me/66994797168&quot;&gt;euwellness&lt;/a&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;

Apretude in Thailand: First Injectable HIV Pre-Exposure Prophylaxis (PrEP) Is Approved